David Urech
47Patents
8h-index
15Co-inventors
68Inventor score
Filing activity: Jun 6, 2006 → Jan 29, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9090684B2 | Stable and soluble antibodies inhibiting VEGF | Chemistry; Metallurgy | 28 | Active |
| US8349322B2 | Stable and soluble antibodies inhibiting VEGF | Chemistry; Metallurgy | 20 | Active |
| US8067547B2 | Stable and soluble antibodies inhibiting TNFα | Chemistry; Metallurgy | 15 | Active |
| US8293235B2 | Humanization of rabbit antibodies using a universal antibody framework | Chemistry; Metallurgy | 15 | Active |
| US8937162B2 | Humanization of rabbit antibodies using a universal antibody framework | Chemistry; Metallurgy | 10 | Active |
| US8673310B2 | Stable and soluble antibodies inhibiting TNFα | Chemistry; Metallurgy | 9 | Active |
| US9422366B2 | Stable and soluble antibodies inhibiting TNF alpha | Chemistry; Metallurgy | 9 | Active |
| US8227199B2 | Methods for identifying immunobinders of cell-surface antigens | Chemistry; Metallurgy | 8 | Active |
| US8545849B2 | Stable and soluble antibodies | Chemistry; Metallurgy | 6 | Active |
| US9873737B2 | Stable and soluble antibodies inhibiting VEGF | Chemistry; Metallurgy | 6 | Active |
| US10590193B2 | Stable and soluble antibodies inhibiting VEGF | Chemistry; Metallurgy | 5 | Active |
| US10100111B2 | Stable and soluble antibodies inhibiting TNF alpha | Chemistry; Metallurgy | 5 | Active |
| US9593161B2 | Humanization of rabbit antibodies using a universal antibody framework | Chemistry; Metallurgy | 5 | Active |
| US10087244B2 | Humanization of rabbit antibodies using a universal antibody framework | Chemistry; Metallurgy | 5 | Active |
| US10077312B2 | CD3 and IL-23 receptor binding bispecific constructs and their use in the treatment of various diseases | Chemistry; Metallurgy | 3 | Active |
| US10570198B2 | Stable and soluble antibodies | Chemistry; Metallurgy | 2 | Active |
| US8796425B2 | Method for decreasing immunogenicity | Chemistry; Metallurgy | 2 | Active |
| US9556265B2 | Solubility optimization of immunobinders | Chemistry; Metallurgy | 2 | Active |
| US8280711B2 | Sequence based engineering and optimization of single chain antibodies | Physics | 2 | Active |
| US9683034B2 | Stable and soluble antibodies inhibiting TNFα | Chemistry; Metallurgy | 2 | Active |
| US9598487B2 | Stable and soluble antibodies | Chemistry; Metallurgy | 1 | Active |
| US9803027B2 | Method for decreasing immunogenicity | Chemistry; Metallurgy | 1 | Active |
| US9221905B2 | Methods for producing immunobinders of cell-surface antigens | Chemistry; Metallurgy | 1 | Active |
| US11236150B2 | Hetero-dimeric multi-specific antibody format | Chemistry; Metallurgy | 1 | Active |
| US8465937B2 | Methods for identifying B-clones which bind cell-surface antigens | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.